HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $61,686,285 | +36.9% | 1,084,118 | -4.8% | 7.80% | +35.3% |
| Q3 2022 | $45,043,000 | -32.9% | 1,139,170 | -25.4% | 5.76% | -24.9% |
| Q2 2022 | $67,157,000 | +8.9% | 1,526,293 | -1.3% | 7.67% | +41.8% |
| Q1 2022 | $61,678,000 | +2.3% | 1,546,592 | +3.1% | 5.41% | +12.2% |
| Q4 2021 | $60,298,000 | -1.6% | 1,499,576 | -0.5% | 4.82% | -6.0% |
| Q3 2021 | $61,283,000 | -0.1% | 1,506,473 | +11.5% | 5.13% | +1.3% |
| Q2 2021 | $61,343,000 | +8.7% | 1,350,870 | -0.2% | 5.06% | +0.7% |
| Q1 2021 | $56,415,000 | +13.5% | 1,353,208 | +16.3% | 5.03% | +9.2% |
| Q4 2020 | $49,709,000 | +74.5% | 1,163,881 | +7.4% | 4.60% | +50.1% |
| Q3 2020 | $28,488,000 | +6.1% | 1,084,015 | +8.2% | 3.07% | -1.3% |
| Q2 2020 | $26,849,000 | – | 1,001,447 | – | 3.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |